Generation of a transgenic mouse for colorectal cancer research with intestinal cre expression limited to the large intestine

Molecular Cancer Research

Volumn 8, Issue 8, 2010, Pages 1095-1104

  Xue, Yingben ^a,c   Johnson, Robert ^b   DeSmet, Marsha ^a   Snyder, Paul W ^b   Fleet, James C ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; DEXTRAN SULFATE;

ADENOMATOSIS POLYPOSIS COLI; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RESEARCH; CECUM; COLON; COLORECTAL CANCER; CONTROLLED STUDY; CRYPT CELL; DISEASE ASSOCIATION; EPITHELIUM CELL; GENE EXPRESSION; GENE INACTIVATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SURFACE PROPERTY; TRANSGENE; TRANSGENIC MOUSE;

ADENOMATOUS POLYPOSIS COLI; ANIMALS; CARBONIC ANHYDRASES; COLORECTAL NEOPLASMS; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; FEMALE; GENES, APC; HUMANS; IMMUNOENZYME TECHNIQUES; INTEGRASES; INTESTINE, LARGE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROMOTER REGIONS, GENETIC; PROTEINS;

MUS; MUS MUSCULUS;

EID: 77955727657     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-10-0195     Document Type: Article

References (38)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-49.
2. Taketo MM, Edelmann W. Mouse models of colon cancer. Gastroenterology 2009;136:780-98.
3. Rosenberg DW, Giardina C, Tanaka T. Mouse models for the study of colon carcinogenesis. Carcinogenesis 2009;30:183-96.
4. Heijstek MW, Kranenburg O, Borel R I. Mouse models of colorectal cancer and liver metastases. Dig Surg 2005;22:16-25. (Pubitemid 40754685)
5. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990; 247:322-4.
6. Colnot S, Niwa-Kawakita M, Hamard G, et al. Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers. Lab Invest 2004;84:1619-30. (Pubitemid 39600569)
7. de Wind N, Dekker M, Berns A, Radman M, te RH. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell 1995;82:321-30.
8. Reitmair AH, Cai JC, Bjerknes M, et al. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis. Cancer Res 1996;56:2922-6. (Pubitemid 26199732)
9. Prolla TA, Baker SM, Harris AC, et al. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nat Genet 1998;18:276-9.
10. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70.
11. Rice P, Longden I, Bleasby A. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet 2000;16:276-7.
12. Sowden J, Edwards M, Morrison K, Butterworth PH, Edwards YH. Erythroid expression and DNAaseI-hypersensitive sites of the carbonic anhydrase 1 gene. Biochem J 1992;288:545-51.
13. Drummond F, Sowden J, Morrison K, Edwards YH. The caudal-type homeobox protein Cdx-2 binds to the colon promoter of the carbonic anhydrase 1 gene. Eur J Biochem 1996;236:670-81. (Pubitemid 26098850)
14. Kuraguchi M, Wang XP, Bronson RT, et al. Adenomatous polyposis coli (APC) is required for normal development of skin and thymus. Plos Genetics 2006;2:1362-74. (Pubitemid 44504788)
15. 3-mediated regulation of transcellular calcium transport in Caco-2 cells. Am J Physiol 1999; 276:G958-64.
16. Braunstein EM, Qiao XTT, Madison B, Pinson K, Dunbar L, Gumucio DL. Villin: a marker for development of the epithelial pyloric border. Dev Dyn 2002;224:90-102. (Pubitemid 34464936)
17. Tanaka T, Kohno H, Suzuki R, et al. Dextran sodium sulfate strongly promotes colorectal carcinogenesis in Apc(Min/+) mice: inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms. Int J Cancer 2006;118:25-34. (Pubitemid 41681577)
18. Sowden J, Leigh S, Talbot I, Delhanty J, Edwards Y. Expression from the proximal promoter of the carbonic anhydrase 1 gene as a marker for differentiation in colon epithelia. Differentiation 1993;53:67-74. (Pubitemid 23240913)
19. Voutsadakis IA. The ubiquitin-proteasome system in colorectal cancer. Biochim Biophys Acta 2008;1782:800-8.
20. Hinoi T, Akyol A, Theisen BK, et al. Mouse model of colonic adenomacarcinoma progression based on somatic Apc inactivation. Cancer Res 2007;67:9721-30. (Pubitemid 47621219)
21. Levy DB, Smith KJ, Beazerbarclay Y, Hamilton SR, Vogelstein B, Kinzler KW. Inactivation of both Apc alleles in human and mouse-tumors. Cancer Res 1994;54:5953-8. (Pubitemid 24375233)
22. Luongo C, Moser AR, Gledhill S, Dove WF. Loss of Apc(+) in intestinal adenomas from min mice. Cancer Res 1994;54:5947-52. (Pubitemid 24375232)
23. Smits R, Kartheuser A, JagmohanChangur S, et al. Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis. Carcinogenesis 1997;18:321-7. (Pubitemid 28132424)
24. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
25. Xie J, Itzkowitz SH. Cancer in inflammatory bowel disease. World J Gastroenterol 2008;14:378-89.
26. Fodde R, Edelmann W, Yang K, et al. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc Natl Acad Sci U S A 1994;91:8969-73.
27. Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, Taketo M. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci U S A 1995;92:4482-6.
28. Cooper HS, Chang WC, Coudry R, et al. Generation of a unique strain of multiple intestinal neoplasia (Apc(+/Min-FCCC)) mice with significantly increased numbers of colorectal adenomas. Mol Carcinog 2005;44:31-41. (Pubitemid 41216405)
29. Madison BB, Dunbar L, Qiao XT, Braunstein K, Braunstein E, Gumucio DL. Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J Biol Chem 2002;277:33275-83. (Pubitemid 34984848)
30. Akyol A, Hinoi T, Feng Y, Bommer GT, Glaser TM, Fearon ER. Generating somatic mosaicism with a Cre recombinase-microsatellite sequence transgene. Nat Methods 2008;5:231-3. (Pubitemid 351325645)
31. Tuveson DA, Shaw AT, Willis NA, et al. Endogenous oncogenic K-ras (G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 2004;5:375-87.
32. Saam JR, Gordon JI. Inducible gene knockouts in the small intestinal and colonic epithelium. J Biol Chem 1999;274:38071-82.
33. Gum JR, Jr., Hicks JW, Crawley SC, et al. Mice expressing SV40 T antigen directed by the intestinal trefoil factor promoter develop tumors resembling human small cell carcinoma of the colon. Mol Cancer Res 2004;2:504-13.
34. Shibata H, Toyama K, Shioya H, et al. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 1997;278:120-3. (Pubitemid 27446290)
35. Hung KE, Maricevich MA, Richard LG, et al. Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment. Proc Natl Acad Sci U S A 2010; 107:1565-70.
36. Miller AJ, Dudley SD, Tsao JL, Shibata D, Liskay RM. Tractable Crelox system for stochastic alteration of genes in mice. Nat Methods 2008;5:227-9. (Pubitemid 351325644)
37. Indra AK, Warot X, Brocard J, et al. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res 1999;27:4324-7.
38. Deschner EE, Long FC, Hakissian M, Herrmann SL. Differential susceptibility of AKR, C57BL/6J, and CF1 mice to 1,2- dimethylhydrazine-induced colonic tumor formation predicted by proliferative characteristics of colonic epithelial cells. J Natl Cancer Inst 1983;70:279-82. (Pubitemid 13164023)